- Home
- HYFM vs ACXP Comparison
HYFM vs ACXP Comparison
Compare HYFM & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- ACXP
- Stock Information
- Founded
- HYFM 1977
- ACXP 2017
- Country
- HYFM United States
- ACXP United States
- Employees
- HYFM N/A
- ACXP N/A
- Industry
- HYFM Industrial Machinery/Components
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- ACXP Health Care
- Exchange
- HYFM Nasdaq
- ACXP Nasdaq
- Market Cap
- HYFM 38.1M
- ACXP 31.4M
- IPO Year
- HYFM 2020
- ACXP 2021
- Fundamental
- Price
- HYFM $0.61
- ACXP $0.85
- Analyst Decision
- HYFM Hold
- ACXP Strong Buy
- Analyst Count
- HYFM 2
- ACXP 1
- Target Price
- HYFM $0.70
- ACXP $12.00
- AVG Volume (30 Days)
- HYFM 114.8K
- ACXP 468.3K
- Earning Date
- HYFM 02-27-2025
- ACXP 03-14-2025
- Dividend Yield
- HYFM N/A
- ACXP N/A
- EPS Growth
- HYFM N/A
- ACXP N/A
- EPS
- HYFM N/A
- ACXP N/A
- Revenue
- HYFM $200,158,000.00
- ACXP N/A
- Revenue This Year
- HYFM N/A
- ACXP N/A
- Revenue Next Year
- HYFM $3.93
- ACXP N/A
- P/E Ratio
- HYFM N/A
- ACXP N/A
- Revenue Growth
- HYFM N/A
- ACXP N/A
- 52 Week Low
- HYFM $0.43
- ACXP $0.68
- 52 Week High
- HYFM $1.20
- ACXP $4.15
- Technical
- Relative Strength Index (RSI)
- HYFM 48.16
- ACXP 47.29
- Support Level
- HYFM $0.55
- ACXP $0.68
- Resistance Level
- HYFM $0.60
- ACXP $0.91
- Average True Range (ATR)
- HYFM 0.05
- ACXP 0.10
- MACD
- HYFM -0.00
- ACXP 0.03
- Stochastic Oscillator
- HYFM 31.40
- ACXP 29.49
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.